Purpurolides D-F (1-3), three new polyoxygenated bergamotanes bearing a 6/4/5/5 tetracyclic ring system, were isolated from the endophytic fungus Penicillium purpurogenum IMM 003. Their structures were unambiguously elucidated based on extensive spectroscopic data analyses, 13 C NMR chemical shifts calculations coupled with the DP4+ probability method, and the calculated and experimental electronic circular dichroism (ECD) spectra. Compounds 1-3 showed significant inhibitory activity against pancreatic lipase (PL). The result highlights that the presence of 3-hydroxylated decanoic acid moiety at C-14 is important for increasing the inhibition potency against PL. [KEY WORDS] Penicillium purpurogenum; Sesquiterpene lactones; Pancreatic lipase inhibitors [CLC Number] R284.1 [Document code] A [Article ID]
Introduction
Obesity and overweight have caused major morbidity and premature death globally due to the modern lifestyle and the high-calorie diet. The increasing prevalence of obesity-associated diseases, including hyperlipidemia, type 2 diabetes, cardiovascular diseases, and certain types of cancers, have shortened the life span and obviously affected the function of many organ systems [1] [2] [3] [4] [5] . Long-term pharmacological treatment of obesity is widely used in clinic, although the number of available drugs is still very limited. One of the practical strategies for the development of anti-obesity drug is to reduce fat digestion absorption in the digestive organs by inhib-iting pancreatic lipase (PL) enzyme [6] [7] .
Microbial secondary metabolites are promising sources of lipase inhibitors, but they have not been explored to the complete extent. Orlistat (Xenical, Roche, Basel, Switzerland), a lipase inhibitor which derived from the lipstatin (obtained from Streptomyces toxytricini), has been approved by the USA Food and Drug Administration (FDA) and European Medical Agency (EMEA), and is available for the long-term treatment of obesity and overweight [8] . Our group is making efforts to search for bioactive natural products from fungi in diverse ecological environmen t [9] [10] [11] [12] [13] [14] [15] [16] . In our previous research, three bergamotane sesquiterpenes with notable structural features and potent inhibitory activity against PL had been isolated from the culture of the endophytic fungus Penicillium purpurogenum IMM 003 [9] . Different strains of P. purpurogenum were reported to represent productive sources of a variety of bioactive meroterpenoids, coumarins, terpenoids, alkaloids, and aromatic compounds with novel structures [17] [18] [19] [20] [21] [22] . Inspired by the above findings, further investigation on the remaining fractions of the solid culture of P. purpurogenum IMM 003 resulted in the discovery of another three new polyoxygenated bergamotanes sharing the 6/4/5/5 tetracyclic ring system, purpurolides D -F (1-3, Fig. 1 ). Herein, we re-port the isolation, structure elucidation, and PL inhibitory activity of 1−3.
Results and Discussion
Purpurolide D (1) 4.20 (s, H-5) , and a methyl at δ H 1.61 (s, H 3 -13) . The 13 C NMR spectrum of 1 showed 15 carbon signals, which were classified as one methyl, four methylenes (including two oxygenated), five methines (including two oxygenated and one olefinic carbon), and five quaternary carbons (including one carbonyl, one olefinic carbon, and two oxygenated sp 3 quaternary carbons) with the aid of HSQC spectra. These data suggested that 1 is similar with the reported 6/4/5/5 tetracyclic bergamotane sesquiterpene purpurolide B [9] , except for the absence of the acetyl substituent. This was confirmed by the 1 H-1 H COSY and HMBC correlations as depicted in Fig. 2 . The relative stereochemistry of 1 containing seven chiral centers was determined using a combination of NOESY correlations coupled with a 13 C NMR chemical shifts calculations. The strong NOESY correlations of H-5/H-7, H-5/H-8a, H-8b/H-12a, and H-14a/H-12b, which However, the stereochemistry of the oxygenated carbons C-2, C-3, and C-4 were left unassigned due to the absence of reliable NOESY correlations. As the 13 C NMR chemical shifts calculations coupled with the DP4+ probability method has shown excellent performance in determining the relative configuration of this kind of compounds [9] . The computationally calculated 13 C NMR data of four diastereomers were compared to the experimental data for 1 and the DP4+ probability analysis indicated that the 2S * , 3R * , 4R * , 5R * , 6R * , 7S * , 9R * -1 was the most relevant candidate with a very high probability of 93.15% (Fig. 3) . The ECD curve is almost identical to purpurolide B whose absolute configuration was secured by single crystal X-ray diffraction analysis using the anomalous scattering of Cu Kα radiation, suggesting that 1 has the same absolute configuration as purpurolide B. This was veri-fied by comparison of the experimental and theoretical ECD spectra predicted using the time-dependent density functional theory (TDDFT) at the B3LYP/6-311+G(d, p) level. The overall pattern of calculated ECD spectrum for 2S, 3R, 4R, 5R, 6R, 7S, 9R stereoisomer was in good agreement with the experimental data of 1 (Fig. 4 ), allowing the assignment of 2S,3R,4R,5R,6R,7S,9R configuration. Purpurolide E (2) was obtained as white powders, and the molecular formula of 2 was established by HR-ESI-MS to be C 15 H 18 O 5 . Compared with the molecular formula of 1, 2 was less of an oxygen atom than 1. The side by side comparison of the 1 H and 13 C NMR (Table 1) data between 2 and 1 revealed that 1 was the OH-15 derivative of 2 because the CH 2 OH moiety in 1 was replaced by a methyl group [δ H 1.70 (3H, dd, J = 4.2, 2.4 Hz, ; δ C 23. 0 (C-15)] in 2. These observations were supported by the HMBC correlations ( Fig. 2 ) from H 3 -15 to C-9, C-10, and C-11, from H-11 to C-7, C-9, and C-15, and from H-9 to C-7, C-11, C-14, and C- (3), obtained as white powers, was assigned the molecular formula of C 25 H 36 O 8 by the positive HR-ESI-MS sodiated molecular ion peak at m/z 487.2297 [M + Na] + (Calcd. for C 25 H 36 O 8 Na, 487.2302), with eight degrees of unsaturation. On comparison of the NMR data of 2 and purpurolide C [9] , a hydroxylated fatty acid or ester moiety rather than an O-methyl group was recognized in 3, based on the signals of δ H 4.06 (1H, m, H-3′), 1.29-2.59 (14H, m, H 2 -2′, H 2 -4′-H 2 -9′), and 0.94 (3H, t, J = 6.6 Hz, H 3 -10′), and δ C 176.5 (C-1 ′). The 1 H− 1 H COSY and HMBC correlations shown in Fig. 2 constructed this moiety as 3-hydroxylated decanoic acid (Fig. 2) . Finally, the HMBC correlations from H-14 to C-3′, indicated that the ketal carbon C-14 connected with C-3 ′ via an ether linkage (Fig. 2) . Like 2, the NOESY correlations, the 13 C NMR chemical shifts computation, and TDDFT-ECD calculations were served to determine the configuration of 3 ( Figs. 3 and 4 ). As expected, the 6/4/5/5 tetracyclic substructure in 3 and purpurolide C possessed identical absolute configurations [9] . Acid hydrolysis of 3 gave 3-hydroxydecanoic acid, of which absolute configuration was assigned as R by its negative[α] D 20 value of −24.0 (c 0.1, CHCl 3 ) [23] [24] . Therefore, the structure of purpurolide F (3) was elucidated as shown in Fig. 1 . Purpurolides D-F (1-3) were evaluated for their inhibitory activity against PL. Purpurolide F (3) had an IC 50 value of 1.22 ± 0.08 μmol·L -1 which was similar in potency to the natural PL inhibitor kaempferol (1.50 ± 0.21 μmol·L -1 ), but less than that of the marketed drug orlistat (0.75 ± 0.11 nmol·L -1 ). It's worth noting that 5 or 6-fold less potent than purpurolide F (3) was observed for purpurolides D (1) and F (2) with IC 50 values of 6.50 ± 0.81 and 7.88 ± 0.88 μmol·L -1 , respectively. This highlights that the presence of 3-hydroxylated decanoic acid moiety at C-14 is important for increasing the potency against PL. In addition, all the isolates were assessed cytotoxicity against HCT-116 colon, BGC-823 stomach, and Bel-7402 hepatoma cell lines, but were inactive at 50 μmol·L -1 . These results suggested that the rare polyoxygenated bergamotanes might be viable candidates for further clinical development as PL inhibitors.
Experimental

General experimental procedures
Optical rotations were measured with a JASCO P-2000 automatic digital polarimeter. UV spectra were recorded on a JASCO V-650 spectrometer. CD spectra were recorded on a JASCO J-815 spectropolarimeter. IR (4000−400 cm −1 ) spectra (KBr pellets) were recorded on a Nicolet 5700 FT-IR spectrophotometer. NMR spectra were obtained on a Bruker-600 spectrometer at 600 MHz for 1 H, and 150 for 13 C, respectively. Chemical shifts given in δ (ppm) using the peak signals of the solvents CD 3 OD (δ H 3.31 and δ C 49.0) as references, and coupling constants are reported in Hz. HR-ESI-MS were obtained on a Thermo Q Exactive Focus mass spectrometer. Silica gel GF 254 prepared for TLC and silica gel (200 to 300 mesh) for column chromatography were obtained from Qingdao Marine Chemical Factory (Qingdao, China) . Sephadex LH-20 was a product of Pharmacia. HPLC analyses were performed on a Waters HPLC instrument (Waters, USA) equipped with a Waters 600 pump, a Waters 2487 dual absorbance detector, and a Grace (250 mm × 10 mm) semipreparative column packed with C 18 (5 μm) . All reagents were HPLC or analytical grade and were purchased from Beijing Chemical Works. TLC was carried out with precoated glass silica gel GF 254 plates (Qingdao Marine Chemical Factory). Spots were visualized under UV light or by spraying with 10% H 2 SO 4 in EtOH followed by heating.
Fungal material
The fresh healthy leaves of Edgeworthia chrysantha were collected from Hangzhou Bay, Hangzhou, Zhejiang Province, China, in December 2012. The selective leaves were surface sterilized by being placed in 75% ethanol for 30 s, 5% NaOCl for 10 min, and rinsing in sterile water and then cultured in Potato Dextrose Agar at 20 ℃ without light. One of the dominant fungal isolations, Penicillium purpurogenum was identified using a molecular biological protocol by DNA amplification and sequencing of ITS region (Beijing Sunbiotech Co., Ltd.). A voucher strain (No. IMM 0003) was deposited at Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
Extraction and isolation
The fungus P. purpurogenum IMM 003 was inoculated in the solid medium of sterile rice in 30 × 1 L conical flasks (each containing 150 g of rice and 0.2 L of tap water, sterilization at 115 °C/68 kPa for 30 min in an autoclave). After incubation at 28 °C for 40 d, the fermented material was extracted with EtOAc (3 × 15 L, each 30 min) using ultrasonic, and the solution was evaporated to dryness under reduced pressure to afford an EtOAc extract (34.0 g).
This crude extract was subjected to silica gel column chromatography employing a petroleum ether−acetone gradient system (50 : 1, 20 : 1, 5 : 1, 3 : 1, 0 : 1) to yield 3 fractions (FA−FC). Subsequently, FB was subjected to silica gel column chromatography employing a petroleum ether−acetone gradient system (20 : 1, 5 : 1, 0 : 1) to yield 11 fractions (FB1−FB11). FB7 (1.2 g) was subjected to further chromatographic separation using RP-C 18 column with a linear gradient MeOH−H 2 O (20%−95%) to yield 5 fractions (FB7-1−FB7-5). FB7-1 (28 mg) was further purified by HPLC (C 18 semipreparative, 5 μm, 250 mm × 10 mm, 205 nm, 75% MeOH−H 2 O, t R = 19.0 min) to yield 3 (6.0 mg). FB7-2 (110 mg) was applied to a Sephadex LH-20 column (2.5 cm × 100 cm, eluted by MeOH) and recrystallized to afford 2 (26.0 mg). FB9 (32 mg) was subjected to a Sephadex LH-20 column (2.5 cm × 100 cm, eluted by MeOH) and was further purified by HPLC (C 18 semipreparative, 5 μm, 250 mm × 10 mm, 205 nm, 39% MeCN−H 2 O, t R = 23.0 min) to yield 1 (0.5 mg). Purpurolide D (1) White powder ( 2.42 (1H, dd, J = 16.4, 8.8 Hz, H-2), 1.20-1.80 (12H, m, H 2 -4 -H 2 -9), 0.88 (3H, t, J = 7.2 Hz, H 3 -10); 13 C NMR (CDCl3) δ: 176.8 (C-1), 41.1(C-2), 68.2 (C-3), 36.7 (C-4), 25.6 (C-5), 29.6 (C-6), 29.4 (C-7), 31.9 (C-8), 22.8 (C-9), 14.2 (C-10) . The NMR data are identical to those of the 3Rhydroxydodecanoic acid reported in the literatures [23] [24] .
Enzyme inhibition assays
The inhibitory effects against pancreatic lipase (PL, Sigma type II) were investigated using 4-methylumbelliferyl oleate (4-MUO) as substrate. Briefly, the incubation mixture with a total volume of 200 μL was consisted of lipase solution (10 μg·mL -1 , final concentration), 0.1 mol·L -1 citrate phosphate buffer (0.1 mol·L -1 citrate-Na 2 HPO 4 , pH 7.4), and each inhibitor, using orlistat and kaempferol as the positive control. After pre-incubation at 37 °C for 10 min, the reaction was started by the addition of 4-methylumbelliferyl oleate (2.5 μmol·L -1 , final concentration), with the final concentration of DMSO at 1% (V/V, without loss of the catalytic activity). All incubations with or without inhibitor were per-formed and 4-MU (the hydrolytic metabolite of 4-MUO) was further analyzed by a multi-Mode microplate reader (Molecular Devices SpectraMax iD3, USA). The florescence signals of the hydrolytic metabolite (4-MU) were real-time monitored under physiological conditions (pH 7.4 at 37 °C) within 30 min incubation, with an interval of 60 s. The excitation wavelength of the hydrolytic metabolite (4-MU) was set at 340 nm, while the emission wavelength was 460 nm. The PMT gain value was set at 100 V and integration time was set 10 ms. The residual activities of lipase were calculated with the following formula: the residual activity (%) = (the florescence intensity in the presence of inhibitor)/the florescence intensity in negative control (DMSO only) × 100.
Cytotoxicity
The cytotoxicity of compounds 1−3 were tested in vitro using human cancer cell lines including HCT-116 colon, BGC-823 stomach, and Bel-7402 hepatoma cell lines. The MTT method was used for the bioassays as described in the literature [9] .
